PGNY
Progyny, Inc. · Healthcare · Medical - Healthcare Plans
Momentum inputs (comparable managers):
holder breadth +12.5% ·
share flow -1.6% ·
net new positions +11.1%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 71.83K | $1.90M | n/a | n/a |
| Q2 2026 | 111 | +7 | 55.02M | $1.59B | +10 | −2 |
| Q1 2026 | 106 | -1 | 57.93M | $989.34M | +8 | −10 |
| Q4 2025 | 108 | +1 | 64.14M | $1.65B | +4 | −2 |
| Q3 2025 | 20 | 0 | 47.53M | $1.02B | +1 | −2 |
| Q2 2025 | 18 | +2 | 41.38M | $910.37M | +2 | n/a |
| Q1 2025 | 13 | +1 | 12.87M | $287.47M | +2 | −1 |
| Q4 2024 | 12 | +3 | 10.40M | $179.35M | +3 | n/a |
| Q3 2024 | 8 | -3 | 5.55M | $93.05M | +1 | −4 |
| Q2 2024 | 11 | n/a | 4.74M | $135.69M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 14.58M | n/a | $320.79M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passive) | 9.87M | n/a | $217.15M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 4.71M | n/a | $103.68M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 4 | State Street Global Advisors ✦ (passive) | 2.87M | -1.6% | $63.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.74M | -3.3% | $38.38M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 1.68M | +7.7% | $37.02M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 1.38M | -6.9% | $30.33M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 8 | Baillie Gifford ✦ | 1.27M | -0.7% | $27.88M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 9 | Renaissance Technologies ✦ | 727.80K | New | $16.01M | 0.0% | New | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 687.46K | +4.0% | $15.12M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 11 | Point72 Asset Management ✦ | 444.74K | New | $9.78M | 0.0% | New | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 426.75K | -67.2% | $9.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 327.39K | -69.3% | $7.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 303.35K | -8.7% | $6.67M | 0.0% | ▼ Trim | 3 | SEC ↗ ×5 |
| 15 | Two Sigma Investments ✦ | 169.69K | -47.4% | $3.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Norges Bank ✦ (passive) | 77.13K | 0.0% | $1.70M | 0.0% | Held | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 59.05K | +7.0% | $1.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 51.86K | +338.1% | $1.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $16.01M | 0.0% |
| Point72 Asset Management | $9.78M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 283 holders, 69.63M shares, $1.17B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.88K sh · $52,612
Officer · 3.90K sh · $101,868
Director · 11.50K sh · $321,358
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology